Evercore ISI Reiterates In-Line Rating for DENTSPLY SIRONA (NASDAQ:XRAY)

Evercore ISI reissued their in-line rating on shares of DENTSPLY SIRONA (NASDAQ:XRAY - Free Report) in a report issued on Tuesday morning, MarketBeat reports. They currently have a $20.00 target price on the medical instruments supplier's stock.

A number of other equities research analysts have also recently weighed in on the stock. Leerink Partnrs cut shares of DENTSPLY SIRONA from a "strong-buy" rating to a "hold" rating in a report on Thursday, November 7th. Leerink Partners cut shares of DENTSPLY SIRONA from an "outperform" rating to a "market perform" rating in a report on Thursday, November 7th. Morgan Stanley cut their price target on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an "overweight" rating on the stock in a report on Tuesday, December 17th. Barrington Research cut their price target on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an "outperform" rating on the stock in a report on Friday, November 8th. Finally, Needham & Company LLC cut their price target on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a "buy" rating on the stock in a report on Friday, October 25th. Nine equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, DENTSPLY SIRONA currently has an average rating of "Hold" and a consensus target price of $27.27.

DENTSPLY SIRONA Price Performance

Shares of XRAY traded down $0.25 during mid-day trading on Tuesday, reaching $18.61. 4,418,641 shares of the stock traded hands, compared to its average volume of 2,699,560. DENTSPLY SIRONA has a 1 year low of $17.21 and a 1 year high of $37.60. The firm has a fifty day moving average price of $19.45 and a 200 day moving average price of $23.21. The company has a market cap of $3.70 billion, a price-to-earnings ratio of -8.99, a price-to-earnings-growth ratio of 1.93 and a beta of 0.96. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.48 by $0.02. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The company had revenue of $951.00 million during the quarter, compared to analyst estimates of $939.10 million. During the same period in the previous year, the business earned $0.49 earnings per share. The firm's quarterly revenue was up .4% compared to the same quarter last year. As a group, equities research analysts predict that DENTSPLY SIRONA will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 10th. Stockholders of record on Friday, December 27th will be given a dividend of $0.16 per share. The ex-dividend date is Friday, December 27th. This represents a $0.64 annualized dividend and a dividend yield of 3.44%. DENTSPLY SIRONA's payout ratio is -30.92%.

Institutional Trading of DENTSPLY SIRONA

Several institutional investors and hedge funds have recently modified their holdings of the company. UMB Bank n.a. increased its holdings in DENTSPLY SIRONA by 430.3% in the 3rd quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier's stock valued at $25,000 after acquiring an additional 753 shares during the last quarter. Capital Performance Advisors LLP bought a new stake in DENTSPLY SIRONA in the 3rd quarter valued at $27,000. Kennebec Savings Bank bought a new stake in DENTSPLY SIRONA in the 3rd quarter valued at $35,000. Van ECK Associates Corp purchased a new position in shares of DENTSPLY SIRONA in the 3rd quarter worth $42,000. Finally, Allworth Financial LP grew its stake in shares of DENTSPLY SIRONA by 40.2% in the 3rd quarter. Allworth Financial LP now owns 2,179 shares of the medical instruments supplier's stock worth $59,000 after buying an additional 625 shares in the last quarter. 95.70% of the stock is currently owned by institutional investors.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.